LifeStance Health Group (LFST)
(Real Time Quote from BATS)
$5.63 USD
+0.12 (2.18%)
Updated Aug 6, 2024 02:40 PM ET
1-Strong Buy of 5 1
D Value F Growth D Momentum F VGM
Price, Consensus and EPS Surprise
LFST 5.63 +0.12(2.18%)
Will LFST be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for LFST based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for LFST
Encompass Health (EHC) Q2 Earnings Beat Estimates
LifeStance Health Group (LFST) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
LFST: What are Zacks experts saying now?
Zacks Private Portfolio Services
Does LifeStance Health (LFST) Have the Potential to Rally 54.84% as Wall Street Analysts Expect?
All You Need to Know About LifeStance Health (LFST) Rating Upgrade to Strong Buy
Wall Street Analysts See a 57.38% Upside in LifeStance Health (LFST): Can the Stock Really Move This High?
Other News for LFST
7 Low-Cost Stocks With Unexpected Growth Potential
LifeStance Survey Finds US Adults Prioritize Access to Therapy Over Free Taylor Swift Tickets and Vacations
LIfeist Shrinks Net Loss: 49% YoY Drop In Q2 Net Revenue, Plans Move Away From Its Legacy Cannabis Business
Lifeist Reports Second Quarter 2024 Financial Results
Lifeist Wellness Pivots Amidst Financial Downturn